re: ann: shareholder update Saverio - its not going to ease your...

re: ann: shareholder update Saverio - its not going to ease your worries - but unfortunately strictly speaking Dr Craven is right.

Efficacy was judged by the ACR-20 (not the ACR-N). Very few subjects (over the placebo) showed a minimally clinically significant improvement.

This has been the state of play for a few months. The current sp troubles seem to be related to possibility that NN may not wish to go forward or perhaps someone with a lot of shares has got there nose out of joint with the recent board / management changes.

For what its worth I thought the recent update was well put togther, spelled things out quite well, and was a bit upbeat. Of-course back then the sp was around 19 cents so shows you how well I read announcements.

Hope it bounces for you mate. Regards Southoz.